OTC : AVEFF
$0 (0.0%)
| Source | Headline |
|---|---|
|
Avecho completes treatment phase for Phase III insomnia trial interim analysis
Avecho Biotechnology Ltd (ASX:AVE, OTC:AVEFF, FRA:OEZ) has completed the treatment phase for the final patient required for the planned interim analysis of... proactiveinvestors.com - 2026-05-21 07:53:00 |